Company / Cost of Revenue
Cytosorbents Corp Cost of Revenue History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$7.5M
FY2018
5-year range
$2.1M / $7.5M
FY2014-FY2018
Trend
+35.7%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $2M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2018 with a 5-year CAGR of +88.0%.
Increased from $2M to $7M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +50.1%
- 5-Year CAGR
- +88.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +88.0%, indicating consistent growth.
- In FY2018, cost of revenue increased 35.7% year-over-year.
- Lowest cost of revenue in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $7.5M | +35.7% |
| FY2017 | $5.5M | +158.6% |
| FY2016 | $2.1M | -3.6% |
| FY2015 | $2.2M | +3.7% |
| FY2014 | $2.1M | +568.3% |
| FY2013 | $319.3K | +0.0% |
| FY2012 | $319.3K | +2615.1% |
| FY2011 | $11.8K | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026